CancerDrs

Breast Cancer clinical trials in North Dakota

9 actively recruiting breast cancer trials at 5 sites across North Dakota.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Academic/Other

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among prem…

Sponsor: NRG Oncology
NCT ID: NCT05879926
Sites in North Dakota:
  • Sanford Bismarck Medical Center — Bismarck, North Dakota
  • Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
  • Sanford South University Medical Center — Fargo, North Dakota
  • Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
  • Sanford Medical Center Fargo — Fargo, North Dakota
View on ClinicalTrials.gov →
Phase 3 Recruiting Network

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are bei…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT03418961
Sites in North Dakota:
  • Sanford Bismarck Medical Center — Bismarck, North Dakota
  • Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
  • Sanford Broadway Medical Center — Fargo, North Dakota
  • Sanford Roger Maris Cancer Center — Fargo, North Dakota
View on ClinicalTrials.gov →
Phase 3 Recruiting Academic/Other

E-Mindfulness Approaches for Living After Breast Cancer

NRG-CC015 is a prospective, randomized phase III clinical trial to evaluate the efficacy of two distinct digital approaches for delivering a mindfulness-based intervention: a live, instructor-led version delivered over Zoom (MAPs LO), and …

Sponsor: NRG Oncology
NCT ID: NCT06748222
Sites in North Dakota:
  • Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
  • Sanford Broadway Medical Center — Fargo, North Dakota
  • Sanford Roger Maris Cancer Center — Fargo, North Dakota
View on ClinicalTrials.gov →
Phase 3 Recruiting Academic/Other

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radia…

Sponsor: NRG Oncology
NCT ID: NCT06500455
Sites in North Dakota:
  • Sanford Broadway Medical Center — Fargo, North Dakota
  • Sanford Roger Maris Cancer Center — Fargo, North Dakota
View on ClinicalTrials.gov →
Phase 3 Recruiting Industry

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Researchers are looking for new ways to treat types of breast cancer that are both: * High-risk, which means the cancer may have a higher chance of getting worse or coming back after treatment * Early-stage, which means the cancer is in th…

Sponsor: Merck Sharp & Dohme LLC
NCT ID: NCT06966700
Sites in North Dakota:
  • Altru Health System ( Site 0057) — Grand Forks, North Dakota
View on ClinicalTrials.gov →
Phase 2 Recruiting NIH

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally adva…

Sponsor: National Cancer Institute (NCI)
NCT ID: NCT05564377
Sites in North Dakota:
  • Sanford Bismarck Medical Center — Bismarck, North Dakota
  • Sanford Broadway Medical Center — Fargo, North Dakota
  • Sanford Roger Maris Cancer Center — Fargo, North Dakota
View on ClinicalTrials.gov →
Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology
NCT ID: NCT05334069
Sites in North Dakota:
  • Sanford Bismarck Medical Center — Bismarck, North Dakota
  • Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
  • Sanford South University Medical Center — Fargo, North Dakota
  • Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
  • Sanford Medical Center Fargo — Fargo, North Dakota
View on ClinicalTrials.gov →
NA Recruiting Network

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

This randomized research trial studies how well serum tumor marker directed disease monitoring works in monitoring patients with hormone receptor positive Her2 negative breast cancer that has spread to other places in the body. Using marke…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT03723928
Sites in North Dakota:
  • Sanford Bismarck Medical Center — Bismarck, North Dakota
  • Sanford South University Medical Center — Fargo, North Dakota
  • Southpointe-Sanford Medical Center Fargo — Fargo, North Dakota
  • Sanford Medical Center Fargo — Fargo, North Dakota
  • Sanford Broadway Medical Center — Fargo, North Dakota
View on ClinicalTrials.gov →
Recruiting Academic/Other

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

This is a multi-site clinical study enrolling 2000 newly diagnosed patients with breast, colorectal, melanoma, non-Hodgkin lymphoma, or non-small cell lung cancer, who are planning to receive one or more systemic cancer directed therapies …

Sponsor: Wake Forest University Health Sciences
NCT ID: NCT06418204
Sites in North Dakota:
  • Essentia Health Cancer Center-South University Clinic — Fargo, North Dakota
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-07-27